(Q33770091)

29 July 2017

title

Fluoroquinolones in paediatrics (English)

1 reference

29 July 2017

Jafri HS

1

1 reference

29 July 2017

McCracken GH Jr

series ordinal

2

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

58 Suppl 2

1 reference

29 July 2017

page(s)

43-48

1 reference

Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children

29 July 2017

cites work

1 reference

12 December 2020

Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI).

1 reference

12 December 2020

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

1 reference

12 December 2020

Multi-drug resistant typhoid fever with diarrhea.

1 reference

12 December 2020

Quinolone arthropathy in animals versus children

1 reference

12 December 2020

Ciprofloxacin: toxicologic evaluation of additional safety data

1 reference

12 December 2020

Clinical features and antibiotic treatment of septic arthritis and osteomyelitis due to Yersinia enterocolitica

1 reference

12 December 2020

Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity

1 reference

12 December 2020

Oral bioavailability of trovafloxacin with and without food in healthy volunteers.

1 reference

12 December 2020

Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns.

1 reference

12 December 2020

Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones

1 reference

12 December 2020

Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.

1 reference

12 December 2020

Atypical cervico-facial mycobacterial infections in childhood

1 reference

12 December 2020

Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety

1 reference

12 December 2020

In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates

1 reference

12 December 2020

Quinolone-resistant Salmonella paratyphi B meningitis in a newborn: a case report

1 reference

12 December 2020

Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

1 reference

12 December 2020

1 reference

12 December 2020

Skull osteomyelitis due to Salmonella species: two case reports and review

1 reference

12 December 2020

Fluoroquinolones in paediatrics--1995.

1 reference

12 December 2020

Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis

1 reference

12 December 2020

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group

1 reference

12 December 2020

Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations.

1 reference

12 December 2020

Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients

1 reference

12 December 2020

1 reference

12 December 2020

Osteomyelitis of the spine due to Salmonella infection--conservative treatment with quinolone: a case report

1 reference

12 December 2020

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

12 December 2020

Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis.

1 reference

12 December 2020

Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group

1 reference

12 December 2020

Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin

1 reference

12 December 2020

Oral Ciprofloxacin for Treatment of Infection Following Nail Puncture Wounds of the Foot

1 reference

12 December 2020

Single-dose and steady-state pharmacokinetics of a new oral suspension of ciprofloxacin in children

1 reference

12 December 2020

Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits

1 reference

12 December 2020

Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy

1 reference

12 December 2020

Use of ciprofloxacin in developing countries

1 reference

12 December 2020

Evolution of susceptibility of non-typhi Salmonella in a Spanish hospital (1992-1994) and report of a Salmonella ser. Typhimurium isolate resistant to quinolones.

1 reference

12 December 2020

Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation

1 reference

12 December 2020

Single dose ciprofloxacin in cholera.

1 reference

12 December 2020

10.2165/00003495-199958002-00008

Identifiers

DOI

0 references

Dimensions Publication ID

1041974914

0 references

1 reference